DigitalSafety

• Kid's Health

84–91% Effective: Clesrovimab Gains FDA Approval to Protect Babies from RSV

DiYES International School – Clesrovimab Gains FDA Approval to protect vulnerable infants from respiratory syncytial virus or RSV during their first exposure…